“…Rodents models, such as transgenic mice, those with pharmacologically-induced neural lesions, and those selectively bred to engage in high or low amount of wheel running or other PA, have helped elucidate the brain regions and molecular mechanisms regulating PA. Because of the strong conservation in brain structure and physiology between rodents and humans (Howdeshell 2002; Rice and Barone 2000), the same brain areas likely facilitate PA in humans. The brain regions in rodents that are essential in modulating this behavior include the striatum, NAc, hypothalamus, amygdala, hippocampus, prefrontal cortex, locus coeruleus, cerebellum, and pons (Ambrogi Lorenzini et al 1991; Andrzejewski et al 2004; Basso and Morrell 2015; Beninger et al 2009; Bronikowski et al 2004; Cahill et al 2015; Dubreucq et al 2010; Kolb et al 2013; Korczynski and Fonberg 1979; Monroe et al 2014; Nonneman and Corwin 1981; Rhodes et al 2003; Roberts et al 2014; Ruegsegger et al 2016; Ruegsegger et al 2015; Tarr et al 2004; Teske et al 2013; Werme et al 2002; Yim and Mogenson 1989). The currently known identified genes and pathways in the brain that are particularly important in stimulating or suppressing this behavioral response include Fos/DeltaFosB (Correa et al 2016; Rhodes et al 2003; Werme et al 2002), CB1 receptors (Dubreucq et al 2010), NMDA receptor (Andrzejewski et al 2004; Yim and Mogenson 1989), dopaminergic (Monroe et al 2014; Roberts et al 2013; Roberts et al 2012; Waters et al 2013; Yang et al 2012)(Park et al Physiology & Behavior, Resubmitted )(Correa et al 2016), opioid (Ruegsegger et al 2015), and leptin (Matheny et al 2009; Ruegsegger et al 2016) signaling pathways.…”